SERPINA1 and alpha 1-antitrypsin deficiency: The patients with AAT deficiency who are treated with augmentation therapy show a pathological genotype but may have normal serum concentrations and phenotype (corresponding to the infused protein), depending on when the AAT replacement therapy was administered.